Kite Reports Real-World Analysis Results of Tecartus (brexucabtagene autoleucel) for Relapsed/Refractory Mantle Cell Lymphoma
Shots: The real-world analysis of Tecartus showed ORR (90%) which was similar to (...
Shots: The real-world analysis of Tecartus showed ORR (90%) which was similar to (...
Shots: The P-III study (TROPiCS-02) evaluating Trodelvy vs CT in a ratio (1:1) in...
Shots: The interim analysis from an ongoing P-II trial evaluating Enhertu (5.4mg/k...
Shots: The P-I study evaluating PK & PD of proposed tocilizumab biosimilar DRL...
Shots: The P-III trial evaluating Tagrisso (80mg, qd) vs PBO in 682 patients with...
Shots: The P-IIb trial evaluating zanidatamab (20mg/kg, IV, q2w) in 87 patients at...
Incisive News in 3 Shots.